210 related articles for article (PubMed ID: 21730273)
1. Variability of lung tumor measurements on repeat computed tomography scans taken within 15 minutes.
Oxnard GR; Zhao B; Sima CS; Ginsberg MS; James LP; Lefkowitz RA; Guo P; Kris MG; Schwartz LH; Riely GJ
J Clin Oncol; 2011 Aug; 29(23):3114-9. PubMed ID: 21730273
[TBL] [Abstract][Full Text] [Related]
2. Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study.
Werner-Wasik M; Xiao Y; Pequignot E; Curran WJ; Hauck W
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):56-61. PubMed ID: 11516851
[TBL] [Abstract][Full Text] [Related]
3. Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer.
Zhao B; James LP; Moskowitz CS; Guo P; Ginsberg MS; Lefkowitz RA; Qin Y; Riely GJ; Kris MG; Schwartz LH
Radiology; 2009 Jul; 252(1):263-72. PubMed ID: 19561260
[TBL] [Abstract][Full Text] [Related]
4. Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response.
Erasmus JJ; Gladish GW; Broemeling L; Sabloff BS; Truong MT; Herbst RS; Munden RF
J Clin Oncol; 2003 Jul; 21(13):2574-82. PubMed ID: 12829678
[TBL] [Abstract][Full Text] [Related]
5. Semiautomatic Analysis on Computed Tomography in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Reproducibility and Prognostic Significance of Unidimensional and 3-dimensional Measurements.
Colombi D; Manna C; Montermini I; Seletti V; Diciotti S; Tiseo M; Fontana E; De Filippo M; Silva M; Sverzellati N
J Thorac Imaging; 2015 Sep; 30(5):290-9. PubMed ID: 25837590
[TBL] [Abstract][Full Text] [Related]
6. Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.
Weber WA; Gatsonis CA; Mozley PD; Hanna LG; Shields AF; Aberle DR; Govindan R; Torigian DA; Karp JS; Yu JQ; Subramaniam RM; Halvorsen RA; Siegel BA; ;
J Nucl Med; 2015 Aug; 56(8):1137-43. PubMed ID: 25908829
[TBL] [Abstract][Full Text] [Related]
7. CT Volumetry and Basic Texture Analysis as Surrogate Markers in Advanced Non-small-cell Lung Cancer.
Owen B; Gandara D; Kelly K; Moore E; Shelton D; Knollmann F
Clin Lung Cancer; 2020 May; 21(3):225-231. PubMed ID: 31699509
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
Liao S; Penney BC; Wroblewski K; Zhang H; Simon CA; Kampalath R; Shih MC; Shimada N; Chen S; Salgia R; Appelbaum DE; Suzuki K; Chen CT; Pu Y
Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983
[TBL] [Abstract][Full Text] [Related]
9. Point: Clinical stage IA non-small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non-small cell lung cancer: the problem of understaging.
Stiles BM; Servais EL; Lee PC; Port JL; Paul S; Altorki NK
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):13-9. PubMed ID: 19154893
[TBL] [Abstract][Full Text] [Related]
10. Measurements of tumor size using CT and PET compared to histopathological size in non-small cell lung cancer.
Aydin F; Dertsiz L; Budak ES; Yildiz A; Ozbilim G; Gungor F
Diagn Interv Radiol; 2013; 19(4):271-8. PubMed ID: 23302288
[TBL] [Abstract][Full Text] [Related]
11. Non-small cell lung carcinoma: accuracy of PET/CT in determining the size of T1 and T2 primary tumors.
Pawaroo D; Cummings NM; Musonda P; Rintoul RC; Rassl D; Beadsmoore C
AJR Am J Roentgenol; 2011 May; 196(5):1176-81. PubMed ID: 21512089
[TBL] [Abstract][Full Text] [Related]
12. Cone-beam CT-based delineation of stereotactic lung targets: the influence of image modality and target size on interobserver variability.
Altorjai G; Fotina I; Lütgendorf-Caucig C; Stock M; Pötter R; Georg D; Dieckmann K
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e265-72. PubMed ID: 21620581
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography-based anatomic assessment overestimates local tumor recurrence in patients with mass-like consolidation after stereotactic body radiotherapy for early-stage non-small cell lung cancer.
Dunlap NE; Yang W; McIntosh A; Sheng K; Benedict SH; Read PW; Larner JM
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1071-7. PubMed ID: 22898383
[TBL] [Abstract][Full Text] [Related]
14. RECIST 1.1 in NSCLC patients with EGFR mutations treated with EGFR tyrosine kinase inhibitors: comparison with RECIST 1.0.
Nishino M; Cardarella S; Jackman DM; Ramaiya NH; Rabin MS; Hatabu H; Jänne PA; Johnson BE
AJR Am J Roentgenol; 2013 Jul; 201(1):W64-71. PubMed ID: 23789698
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer: computerized quantification of tumor response--initial results.
Zhao B; Schwartz LH; Moskowitz CS; Ginsberg MS; Rizvi NA; Kris MG
Radiology; 2006 Dec; 241(3):892-8. PubMed ID: 17114630
[TBL] [Abstract][Full Text] [Related]
17. Non-small-cell lung cancer dimensions: CT-pathological correlation and interobserver variation.
Macpherson RE; Higgins GS; Murchison JT; Wallace WA; Price A; Gaffney S; Erridge SC
Br J Radiol; 2009 May; 82(977):421-5. PubMed ID: 19153186
[TBL] [Abstract][Full Text] [Related]
18. Volumetric and linear measurements of lung tumor burden from non-gated micro-CT imaging correlate with histological analysis in a genetically engineered mouse model of non-small cell lung cancer.
Gallastegui A; Cheung J; Southard T; Hume KR
Lab Anim; 2018 Oct; 52(5):457-469. PubMed ID: 29436921
[TBL] [Abstract][Full Text] [Related]
19. Molecularly targeted therapy using bevacizumab for non-small cell lung cancer: a pilot study for the new CT response criteria.
Lee HY; Lee KS; Hwang HS; Lee JW; Ahn MJ; Park K; Kim TS; Yi CA; Chung MJ
Korean J Radiol; 2010; 11(6):618-26. PubMed ID: 21076587
[TBL] [Abstract][Full Text] [Related]
20. Rapid disease progression with delay in treatment of non-small-cell lung cancer.
Mohammed N; Kestin LL; Grills IS; Battu M; Fitch DL; Wong CY; Margolis JH; Chmielewski GW; Welsh RJ
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):466-72. PubMed ID: 20471184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
